Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation-Reference-Cited by-同舟云学术

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

Published:2016-04-22 Issue:11 Volume:46 Page:1118-1128
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Shinoda Masahiro¹,Ebinuma Hirotoshi²,Itano Osamu¹,Yamagishi Yoshiyuki²,Obara Hideaki¹,Kitago Minoru¹,Nakamoto Nobuhiro²,Hibi Taizo¹,Yagi Hiroshi¹,Abe Yuta¹,Matsubara Kentaro¹,Chu Po‐sung²,Wakayama Yuko²,Taniki Nobuhito²,Yamaguchi Akihiro²,Amemiya Ryusuke¹,Miyake Rei²,Mizota Takamasa¹,Kanai Takanori²,Kitagawa Yuko¹

Affiliation:

1. Department of Surgery

2. Division of Gastroenterology & Hepatology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.12666

Reference32 articles.

1. WHO.WHO Fact Sheet number 164. – Hepatitis C. In;2012.

3. The association between hepatitis C infection and survival after orthotopic liver transplantation

4. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey

5. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral therapy of hepatitis C with 1 genotype after liver transplantation;Russian Journal of Transplantology and Artificial Organs;2018-09-17

2. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis;Hepatitis Monthly;2017-06-17

3. Everolimus;Reactions Weekly;2016-12

4. Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review;Hepatology International;2016-06-23